SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-040803
Filing Date
2015-05-08
Accepted
2015-05-08 19:48:42
Documents
1
Period of Report
2015-05-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12263
  Complete submission text file 0001209191-15-040803.txt   13673
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 650-745-7802
HYPERION THERAPEUTICS INC (Issuer) CIK: 0001386858 (see all company filings)

IRS No.: 611512713 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NAVIMED CAPITAL 1333 H STREET NW, SUITE 400 WEST WASHINGTON DC 20005
Business Address
Salehizadeh Bijan (Reporting) CIK: 0001552056 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35614 | Film No.: 15848539